Evaluation of Bile Acid Concentrations and Their Signaling as Markers of Testicular Tumorigenesis and Germ Cell Tumor Chemosensitivity

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18+
SponsorUniversity Hospital, Clermont-Ferrand

About this trial

This is a study exploring measurable markers in the blood of patients with testicular tumors. The investigators will focus on the importance of measuring and analyzing these markers for their prognostic value and predictive response to treatment.

Eligibility criteria

Qualifiers

Adult patient, male, with a clinical and biological diagnosis of germ cell tumor of the testis in pre-orchidectomy, at the stage of the disease and any histological subtype of germ cell tumor

Affiliation with a Social Security organization

Able to give informed consent to participate in the research.

Disqualifiers

Patient with a hepatobiliary pathology

Patient treated with Colestyramine

Patient who has undergone cholecystectomy or extensive resection of the small intestine

Patient deprived of liberty

Trial design

Treatments tested in this trial

  • blood sampling
  • Tissue sampling

Treatment groups

20 Participants
are divided into 1 treatment group